Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07487818 · ClinicalTrials.gov registry record · Phase 2
A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation
A Phase 2 study, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT07487818: Recruiting Phase 2 study, sponsored by Mayo Clinic.
NCT07487818 is a Phase 2 study that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07487818, a Phase 2 study, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to provide preliminary evidence for the efficacy of 12 weeks of vagal nerve stimulation (VNS) and nicotine replacement therapy (NRT) for increasing smoking abstinence rates.
Interventions
- COMBINATION_PRODUCT Non-invasive vagus nerve stimulator plus nicotine replacement patches
- DRUG nicotine replacement patches
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-04-15 |
| Est. Completion | 2027-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07487818
The ClinicalTrials.gov registry entry for NCT07487818 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Non-invasive vagus nerve stimulator plus nicotine replacement patches is the first listed.
NCT07487818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07487818 about?
NCT07487818 is a clinical study titled "A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation". The purpose of this study is to provide preliminary evidence for the efficacy of 12 weeks of vagal nerve stimulation (VNS) and nicotine replacement therapy (NRT) for increasing smoking abstinence rates.
What is the current status of trial NCT07487818?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2026-04-15. Estimated completion is 2027-05-31.
What interventions are being tested in trial NCT07487818?
The interventions under investigation include: Non-invasive vagus nerve stimulator plus nicotine replacement patches (COMBINATION_PRODUCT), nicotine replacement patches (DRUG).
Who is sponsoring clinical trial NCT07487818?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.